GAM
BIVV

Gotham Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gotham Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-152,666
Closed -$8.23M – 1146
2017
Q4 		$8.23M Sell
152,666
-234,324
-61% -$12.8M 0.12% 260
2017
Q3 		$22.1M Buy
386,990
+159,613
+70% +$9.35M 0.32% 80
2017
Q2 		$13.7M Buy
227,377
+117,470
+107% +$6.69M 0.19% 174
2017
Q1 		$5.99M Buy
+109,907
New +$5.41M 0.08% 356

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gotham Asset Management's BIVV Position: Q1 2018 in Review

Gotham Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 152,666 shares — an estimated $8.23M sold.

Gotham Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $22.1M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Gotham Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Gotham Asset Management sold 152,666 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $8.23M.
  • Gotham Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Gotham Asset Management's Bioverativ Inc. Common Stock position peaked at $22.1M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gotham Asset Management's 13F filing for Q1 2018, filed 15 May 2018.